India CDMO Market: Growth Opportunities and Considerations

India CDMO Market: Growth Opportunities and Considerations

Market Position

India is a major global pharmaceutical manufacturing hub, particularly for generic drugs and APIs.

Key Strengths

Cost Advantage

• Competitive pricing
• Lower operational costs
• Skilled workforce

Regulatory Status

• FDA-approved facilities
• WHO prequalification
• EU GMP certifications

Capabilities

• API manufacturing
• Formulation development
• Packaging services

Considerations

Quality Management

• Variable quality standards
• Need for careful due diligence
• Importance of site audits

Regulatory Challenges

• Import alert history
• Data integrity concerns
• Inspection frequency

Selection Criteria

1. Regulatory track record
2. Quality system maturity
3. Capacity and capabilities
4. Financial stability

Future Outlook

• Continued API dominance
• Growing biologics capacity
• Quality improvements underway